إعلان
إعلان
MXCT
MaxCyte, Inc. Common Stock
1.43
USDبرعاية
-0.03
-2.38%
٠٩ يناير, ١٥:٤٨ UTC -5
مغلق
قبل الإفتتاح
1.44
+0.01
+0.70%
تقارير أرباح MXCT
النسبة الإيجابية المفاجئة
MXCT تفوق 15 من 18 آخر التقديرات.
83%
التقرير التالي
بيانات التقرير القادم
٠٢ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$9.59M
/-$0.08
التغير الضمني من Q3 25 (Revenue/ EPS)
+40.49%
/-11.11%
التغير الضمني من Q4 24 (Revenue/ EPS)
+10.37%
/-20.00%
MaxCyte, Inc. Common Stock earnings per share and revenue
On ١٢ نوفمبر ٢٠٢٥, MXCT reported earnings of -0.09 USD per share (EPS) for Q3 25, beating the estimate of -0.11 USD, resulting in a 19.79% surprise. Revenue reached 6.83 مليون, compared to an expected 8.54 مليون, with a -20.01% difference. The market reacted with a -4.43% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 8 المحللين forecast an EPS of -0.08 USD, with revenue projected to reach 9.59 مليون USD, implying an نقصان of -11.11% EPS, and زيادة of 40.49% in Revenue from the last quarter.
الأسئلة الشائعة
What were MaxCyte, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, MaxCyte, Inc. Common Stock reported EPS of -$0.09, beating estimates by 19.79%, and revenue of $6.83M, -20.01% below expectations.
How did the market react to MaxCyte, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -4.43%, changed from $1.58 before the earnings release to $1.51 the day after.
When is MaxCyte, Inc. Common Stock expected to report next?
The next earning report is scheduled for ٠٢ مارس ٢٠٢٦.
What are the forecasts for MaxCyte, Inc. Common Stock's next earnings report?
Based on 8
المحللين, MaxCyte, Inc. Common Stock is expected to report EPS of -$0.08 and revenue of $9.59M for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان